Matches in SemOpenAlex for { <https://semopenalex.org/work/W1486021931> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W1486021931 endingPage "63" @default.
- W1486021931 startingPage "2158" @default.
- W1486021931 abstract "A monoclonal antibody, Hepama-1, produced by immunizing mice with cells of a human hepatocellular carcinoma cell line, has been used to identify and characterize a previously unreported antigen present on the surface of human hepatocellular carcinoma cells. The antigen occurred on the membranes of human hepatoma cell lines and tumor biopsies but was not detectable in tumors of other origin or normal tissues. Binding was determined by enzyme-linked immunoabsorbent assay and immunofluorescence on cell lines and by immunoperoxidase staining of tissue sections. In immunofluorescence studies, Hepama-1 antibodies stained five out of six human hepatoma cell lines, showed only slight binding to breast tumor cell lines, but failed to stain colon tumor or normal cell lines. The antihepatoma antibody exhibited positive immunoperoxidase staining of human liver tumor sections but did not stain tumors of other origin. Hepama-1 bound specifically to a membrane glycoprotein with an approximate molecular weight of 43,000. Western blot and solid phase enzyme-linked immunoabsorbent assay analysis showed that the 43-kD antigen occurred on five of six human hepatoma cell lines and was expressed by every human hepatocellular carcinoma biopsy tested. This cell surface molecule represents a potentially useful target for immunotherapy and localization of human hepatocellular carcinomas." @default.
- W1486021931 created "2016-06-24" @default.
- W1486021931 creator A5000858669 @default.
- W1486021931 creator A5004154569 @default.
- W1486021931 creator A5034462876 @default.
- W1486021931 creator A5058467967 @default.
- W1486021931 creator A5082834847 @default.
- W1486021931 date "1991-04-15" @default.
- W1486021931 modified "2023-09-26" @default.
- W1486021931 title "Characterization of a membrane-associated glycoprotein (gp 43) on human hepatocellular carcinoma by a monoclonal antibody." @default.
- W1486021931 cites W1588885776 @default.
- W1486021931 cites W1897720314 @default.
- W1486021931 cites W2076300996 @default.
- W1486021931 cites W2100837269 @default.
- W1486021931 cites W2102298336 @default.
- W1486021931 cites W2111817213 @default.
- W1486021931 cites W2114930204 @default.
- W1486021931 cites W2150087209 @default.
- W1486021931 cites W2162389703 @default.
- W1486021931 cites W2353592568 @default.
- W1486021931 cites W2359146829 @default.
- W1486021931 cites W2400196026 @default.
- W1486021931 cites W2474779830 @default.
- W1486021931 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1849045" @default.
- W1486021931 hasPublicationYear "1991" @default.
- W1486021931 type Work @default.
- W1486021931 sameAs 1486021931 @default.
- W1486021931 citedByCount "3" @default.
- W1486021931 crossrefType "journal-article" @default.
- W1486021931 hasAuthorship W1486021931A5000858669 @default.
- W1486021931 hasAuthorship W1486021931A5004154569 @default.
- W1486021931 hasAuthorship W1486021931A5034462876 @default.
- W1486021931 hasAuthorship W1486021931A5058467967 @default.
- W1486021931 hasAuthorship W1486021931A5082834847 @default.
- W1486021931 hasConcept C128102431 @default.
- W1486021931 hasConcept C142724271 @default.
- W1486021931 hasConcept C147483822 @default.
- W1486021931 hasConcept C1491633281 @default.
- W1486021931 hasConcept C153911025 @default.
- W1486021931 hasConcept C159654299 @default.
- W1486021931 hasConcept C203014093 @default.
- W1486021931 hasConcept C2778019345 @default.
- W1486021931 hasConcept C2778236600 @default.
- W1486021931 hasConcept C2781294515 @default.
- W1486021931 hasConcept C502942594 @default.
- W1486021931 hasConcept C542903549 @default.
- W1486021931 hasConcept C54355233 @default.
- W1486021931 hasConcept C55493867 @default.
- W1486021931 hasConcept C71924100 @default.
- W1486021931 hasConcept C74864618 @default.
- W1486021931 hasConcept C81885089 @default.
- W1486021931 hasConcept C86803240 @default.
- W1486021931 hasConceptScore W1486021931C128102431 @default.
- W1486021931 hasConceptScore W1486021931C142724271 @default.
- W1486021931 hasConceptScore W1486021931C147483822 @default.
- W1486021931 hasConceptScore W1486021931C1491633281 @default.
- W1486021931 hasConceptScore W1486021931C153911025 @default.
- W1486021931 hasConceptScore W1486021931C159654299 @default.
- W1486021931 hasConceptScore W1486021931C203014093 @default.
- W1486021931 hasConceptScore W1486021931C2778019345 @default.
- W1486021931 hasConceptScore W1486021931C2778236600 @default.
- W1486021931 hasConceptScore W1486021931C2781294515 @default.
- W1486021931 hasConceptScore W1486021931C502942594 @default.
- W1486021931 hasConceptScore W1486021931C542903549 @default.
- W1486021931 hasConceptScore W1486021931C54355233 @default.
- W1486021931 hasConceptScore W1486021931C55493867 @default.
- W1486021931 hasConceptScore W1486021931C71924100 @default.
- W1486021931 hasConceptScore W1486021931C74864618 @default.
- W1486021931 hasConceptScore W1486021931C81885089 @default.
- W1486021931 hasConceptScore W1486021931C86803240 @default.
- W1486021931 hasIssue "8" @default.
- W1486021931 hasLocation W14860219311 @default.
- W1486021931 hasOpenAccess W1486021931 @default.
- W1486021931 hasPrimaryLocation W14860219311 @default.
- W1486021931 hasRelatedWork W114996293 @default.
- W1486021931 hasRelatedWork W136589371 @default.
- W1486021931 hasRelatedWork W1582033604 @default.
- W1486021931 hasRelatedWork W1989289676 @default.
- W1486021931 hasRelatedWork W2073262237 @default.
- W1486021931 hasRelatedWork W2123042378 @default.
- W1486021931 hasRelatedWork W2168239348 @default.
- W1486021931 hasRelatedWork W2322850625 @default.
- W1486021931 hasRelatedWork W2402810366 @default.
- W1486021931 hasRelatedWork W4984490 @default.
- W1486021931 hasVolume "51" @default.
- W1486021931 isParatext "false" @default.
- W1486021931 isRetracted "false" @default.
- W1486021931 magId "1486021931" @default.
- W1486021931 workType "article" @default.